speb/financial-data huggingface dataset:
CNP cash_flow (annual, 2022-12-31) — Depreciation Amortization Depletion: 1288000000.00
CNP income_statement (annual, 2022-12-31) — Depreciation Amortization Depletion Income Statement: 1288000000.00
CNP cash_flow (annual, 2022-12-31) — Depreciation And Amortization: 1288000000.00
CNP income_statement (annual, 2022-12-31) — Depreciation And Amortization In Income Statement: 1288000000.00
CNP balance_sheet (annual, 2022-12-31) — Derivative Product Liabilities: 0.00
CNP income_statement (annual, 2022-12-31) — Diluted Average Shares: 632346000.00
CNP income_statement (annual, 2022-12-31) — Diluted EPS: 1.59
CNP income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: 1008000000.00
CNP cash_flow (annual, 2022-12-31) — Dividend Received Cfo: 0.00
CNP balance_sheet (annual, 2022-12-31) — Dividends Payable: 144000000.00
CNP cash_flow (annual, 2022-12-31) — Dividends Received Cfi: 0.00
CNP income_statement (annual, 2022-12-31) — EBIT: 1941000000.00
CNP income_statement (annual, 2022-12-31) — EBITDA: 3229000000.00
CNP cash_flow (annual, 2022-12-31) — Earnings Losses From Equity Investments: 0.00
CNP balance_sheet (annual, 2022-12-31) — Employee Benefits: 547000000.00
CNP cash_flow (annual, 2022-12-31) — End Cash Position: 91000000.00
CNP balance_sheet (annual, 2022-12-31) — Financial Assets: 2000000.00
CNP cash_flow (annual, 2022-12-31) — Financing Cash Flow: -345000000.00
CNP cash_flow (annual, 2022-12-31) — Free Cash Flow: -2609000000.00
CNP cash_flow (annual, 2022-12-31) — Gain Loss On Investment Securities: -98000000.00
CNP cash_flow (annual, 2022-12-31) — Gain Loss On Sale Of Business: -303000000.00
CNP income_statement (annual, 2022-12-31) — Gain On Sale Of Business: 303000000.00
CNP income_statement (annual, 2022-12-31) — Gain On Sale Of Security: 98000000.00
CNP balance_sheet (annual, 2022-12-31) — Gains Losses Not Affecting Retained Earnings: -31000000.00
CNP balance_sheet (annual, 2022-12-31) — Goodwill: 4294000000.00
CNP balance_sheet (annual, 2022-12-31) — Goodwill And Other Intangible Assets: 4294000000.00
CNP balance_sheet (annual, 2022-12-31) — Gross Accounts Receivable: 927000000.00
CNP balance_sheet (annual, 2022-12-31) — Gross PPE: 37728000000.00
CNP income_statement (annual, 2022-12-31) — Gross Profit: 3397000000.00
CNP balance_sheet (annual, 2022-12-31) — Hedging Assets Current: 10000000.00
CNP income_statement (annual, 2022-12-31) — Impairment Of Capital Assets: 0.00
CNP cash_flow (annual, 2022-12-31) — Income Tax Paid Supplemental Data: 421000000.00
CNP income_statement (annual, 2022-12-31) — Interest Expense: 524000000.00
CNP income_statement (annual, 2022-12-31) — Interest Expense Non Operating: 524000000.00
CNP cash_flow (annual, 2022-12-31) — Interest Paid Supplemental Data: 480000000.00
CNP balance_sheet (annual, 2022-12-31) — Interest Payable: 159000000.00
CNP balance_sheet (annual, 2022-12-31) — Inventory: 876000000.00
CNP balance_sheet (annual, 2022-12-31) — Invested Capital: 26111000000.00
CNP cash_flow (annual, 2022-12-31) — Investing Cash Flow: -1628000000.00
CNP cash_flow (annual, 2022-12-31) — Issuance Of Capital Stock: 0.00
CNP cash_flow (annual, 2022-12-31) — Issuance Of Debt: 2541000000.00
CNP balance_sheet (annual, 2022-12-31) — Long Term Debt: 14836000000.00
CNP balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 14836000000.00
CNP cash_flow (annual, 2022-12-31) — Long Term Debt Issuance: 2089000000.00
CNP cash_flow (annual, 2022-12-31) — Long Term Debt Payments: -2280000000.00
CNP cash_flow (annual, 2022-12-31) — Net Business Purchase And Sale: 2075000000.00
CNP cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: 0.00
CNP balance_sheet (annual, 2022-12-31) — Net Debt: 16782000000.00
CNP income_statement (annual, 2022-12-31) — Net Income: 1057000000.00
CNP income_statement (annual, 2022-12-31) — Net Income Common Stockholders: 1008000000.00
CNP income_statement (annual, 2022-12-31) — Net Income Continuous Operations: 1057000000.00
CNP income_statement (annual, 2022-12-31) — Net Income Discontinuous Operations: 0.00
CNP income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: 1057000000.00
CNP income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: 1057000000.00
CNP cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: 1057000000.00
CNP income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: 1057000000.00
CNP income_statement (annual, 2022-12-31) — Net Interest Income: -524000000.00
CNP cash_flow (annual, 2022-12-31) — Net Investment Purchase And Sale: 702000000.00
CNP cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: 187000000.00
CNP cash_flow (annual, 2022-12-31) — Net Long Term Debt Issuance: -191000000.00
CNP income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: -524000000.00
CNP cash_flow (annual, 2022-12-31) — Net Other Financing Charges: -43000000.00
CNP cash_flow (annual, 2022-12-31) — Net Other Investing Changes: 14000000.00
CNP balance_sheet (annual, 2022-12-31) — Net PPE: 27143000000.00
CNP cash_flow (annual, 2022-12-31) — Net Preferred Stock Issuance: 0.00
CNP cash_flow (annual, 2022-12-31) — Net Short Term Debt Issuance: 378000000.00
CNP balance_sheet (annual, 2022-12-31) — Net Tangible Assets: 5751000000.00
CNP balance_sheet (annual, 2022-12-31) — Non Current Deferred Liabilities: 3986000000.00
CNP balance_sheet (annual, 2022-12-31) — Non Current Deferred Taxes Liabilities: 3986000000.00
CNP balance_sheet (annual, 2022-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 547000000.00
CNP income_statement (annual, 2022-12-31) — Normalized EBITDA: 2828000000.00
CNP income_statement (annual, 2022-12-31) — Normalized Income: 757877205.36
CNP cash_flow (annual, 2022-12-31) — Operating Cash Flow: 1810000000.00
CNP cash_flow (annual, 2022-12-31) — Operating Gains Losses: -401000000.00
CNP income_statement (annual, 2022-12-31) — Operating Income: 1566000000.00
CNP income_statement (annual, 2022-12-31) — Operating Revenue: 9321000000.00
CNP balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 629535631.00
CNP balance_sheet (annual, 2022-12-31) — Other Current Assets: 1556000000.00
CNP balance_sheet (annual, 2022-12-31) — Other Current Borrowings: 2020000000.00
CNP balance_sheet (annual, 2022-12-31) — Other Current Liabilities: 1030000000.00
CNP balance_sheet (annual, 2022-12-31) — Other Equity Adjustments: -31000000.00
CNP income_statement (annual, 2022-12-31) — Other Income Expense: 375000000.00
CNP balance_sheet (annual, 2022-12-31) — Other Intangible Assets: 38000000.00
CNP balance_sheet (annual, 2022-12-31) — Other Inventories: 241000000.00
CNP cash_flow (annual, 2022-12-31) — Other Non Cash Items: 44000000.00
CNP balance_sheet (annual, 2022-12-31) — Other Non Current Assets: 215000000.00
CNP balance_sheet (annual, 2022-12-31) — Other Non Current Liabilities: 774000000.00
CNP income_statement (annual, 2022-12-31) — Other Non Operating Income Expenses: -26000000.00
CNP balance_sheet (annual, 2022-12-31) — Other Properties: 1357000000.00
CNP balance_sheet (annual, 2022-12-31) — Other Short Term Investments: 510000000.00
CNP income_statement (annual, 2022-12-31) — Other Taxes: 543000000.00
CNP income_statement (annual, 2022-12-31) — Otherunder Preferred Stock Dividend: 0.00
CNP balance_sheet (annual, 2022-12-31) — Payables: 1794000000.00
CNP balance_sheet (annual, 2022-12-31) — Payables And Accrued Expenses: 1953000000.00
CNP balance_sheet (annual, 2022-12-31) — Preferred Stock: 790000000.00
CNP cash_flow (annual, 2022-12-31) — Preferred Stock Dividend Paid: -49000000.00
CNP income_statement (annual, 2022-12-31) — Preferred Stock Dividends: 49000000.00
CNP balance_sheet (annual, 2022-12-31) — Preferred Stock Equity: 790000000.00
CNP cash_flow (annual, 2022-12-31) — Preferred Stock Issuance: 0.00
CNP cash_flow (annual, 2022-12-31) — Preferred Stock Payments: 0.00
CNP income_statement (annual, 2022-12-31) — Pretax Income: 1417000000.00
CNP balance_sheet (annual, 2022-12-31) — Receivables: 1673000000.00
CNP income_statement (annual, 2022-12-31) — Reconciled Cost Of Revenue: 5924000000.00
CNP income_statement (annual, 2022-12-31) — Reconciled Depreciation: 1288000000.00
CNP cash_flow (annual, 2022-12-31) — Repayment Of Debt: -2354000000.00
CNP cash_flow (annual, 2022-12-31) — Repurchase Of Capital Stock: 0.00
CNP balance_sheet (annual, 2022-12-31) — Retained Earnings: 709000000.00
CNP cash_flow (annual, 2022-12-31) — Sale Of Business: 2075000000.00
CNP cash_flow (annual, 2022-12-31) — Sale Of Investment: 702000000.00
CNP balance_sheet (annual, 2022-12-31) — Share Issued: 629535631.00
CNP cash_flow (annual, 2022-12-31) — Short Term Debt Issuance: 452000000.00
CNP cash_flow (annual, 2022-12-31) — Short Term Debt Payments: -74000000.00
CNP income_statement (annual, 2022-12-31) — Special Income Charges: 303000000.00
CNP balance_sheet (annual, 2022-12-31) — Stockholders Equity: 10045000000.00
CNP balance_sheet (annual, 2022-12-31) — Tangible Book Value: 4961000000.00
CNP income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: 101877205.36
CNP income_statement (annual, 2022-12-31) — Tax Provision: 360000000.00
CNP income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.25
CNP balance_sheet (annual, 2022-12-31) — Taxes Receivable: 20000000.00
CNP balance_sheet (annual, 2022-12-31) — Total Assets: 38546000000.00
CNP balance_sheet (annual, 2022-12-31) — Total Capitalization: 24881000000.00
CNP balance_sheet (annual, 2022-12-31) — Total Debt: 16856000000.00
CNP balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 10045000000.00
CNP income_statement (annual, 2022-12-31) — Total Expenses: 7755000000.00
CNP balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 28501000000.00
CNP balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 33847000000.00
CNP balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 23388000000.00
CNP income_statement (annual, 2022-12-31) — Total Operating Income As Reported: 1566000000.00
CNP balance_sheet (annual, 2022-12-31) — Total Tax Payable: 298000000.00
CNP income_statement (annual, 2022-12-31) — Total Unusual Items: 401000000.00
CNP income_statement (annual, 2022-12-31) — Total Unusual Items Excluding Goodwill: 401000000.00
CNP balance_sheet (annual, 2022-12-31) — Working Capital: -414000000.00
CNP income_statement (annual, 2023-12-31) — +Operating Expense: 1926000000.00
CNP income_statement (annual, 2023-12-31) — +Total Revenue: 8696000000.00
CNP balance_sheet (annual, 2023-12-31) — Accounts Payable: 917000000.00
CNP balance_sheet (annual, 2023-12-31) — Accounts Receivable: 710000000.00
CNP balance_sheet (annual, 2023-12-31) — Accumulated Depreciation: -10543000000.00
CNP balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 8604000000.00
CNP balance_sheet (annual, 2023-12-31) — Allowance For Doubtful Accounts Receivable: -27000000.00
CNP cash_flow (annual, 2023-12-31) — Amortization Cash Flow: 309000000.00
CNP cash_flow (annual, 2023-12-31) — Amortization Of Intangibles: 309000000.00
CNP balance_sheet (annual, 2023-12-31) — Assets Held For Sale Current: 0.00
CNP income_statement (annual, 2023-12-31) — Basic Average Shares: 631000000.00
CNP income_statement (annual, 2023-12-31) — Basic EPS: 1.37
CNP cash_flow (annual, 2023-12-31) — Beginning Cash Position: 91000000.00
CNP cash_flow (annual, 2023-12-31) — Capital Expenditure: -4401000000.00
CNP cash_flow (annual, 2023-12-31) — Capital Expenditure Reported: -4401000000.00
CNP balance_sheet (annual, 2023-12-31) — Capital Stock: 6000000.00
CNP balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 90000000.00
CNP balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 631000000.00
CNP cash_flow (annual, 2023-12-31) — Cash Dividends Paid: -535000000.00
CNP cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Financing Activities: 374000000.00
CNP cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Investing Activities: -4233000000.00
CNP cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Operating Activities: 3877000000.00
CNP cash_flow (annual, 2023-12-31) — Change In Account Payable: -302000000.00
CNP cash_flow (annual, 2023-12-31) — Change In Inventory: 167000000.00
CNP cash_flow (annual, 2023-12-31) — Change In Other Current Assets: 1121000000.00
CNP cash_flow (annual, 2023-12-31) — Change In Other Current Liabilities: 82000000.00
CNP cash_flow (annual, 2023-12-31) — Change In Other Working Capital: 1277000000.00
CNP cash_flow (annual, 2023-12-31) — Change In Payable: -302000000.00
CNP cash_flow (annual, 2023-12-31) — Change In Payables And Accrued Expense: -302000000.00
CNP cash_flow (annual, 2023-12-31) — Change In Receivables: 423000000.00
CNP cash_flow (annual, 2023-12-31) — Change In Working Capital: 1491000000.00
CNP cash_flow (annual, 2023-12-31) — Changes In Account Receivables: 423000000.00
CNP cash_flow (annual, 2023-12-31) — Changes In Cash: 18000000.00
CNP balance_sheet (annual, 2023-12-31) — Common Stock: 6000000.00
CNP cash_flow (annual, 2023-12-31) — Common Stock Dividend Paid: -485000000.00
CNP balance_sheet (annual, 2023-12-31) — Common Stock Equity: 9667000000.00
CNP cash_flow (annual, 2023-12-31) — Common Stock Issuance: 0.00
CNP income_statement (annual, 2023-12-31) — Cost Of Revenue: 5010000000.00
CNP balance_sheet (annual, 2023-12-31) — Current Accrued Expenses: 236000000.00
CNP balance_sheet (annual, 2023-12-31) — Current Assets: 3027000000.00
CNP balance_sheet (annual, 2023-12-31) — Current Debt: 1059000000.00
CNP balance_sheet (annual, 2023-12-31) — Current Debt And Capital Lease Obligation: 1059000000.00
CNP balance_sheet (annual, 2023-12-31) — Current Deferred Liabilities: 111000000.00
CNP balance_sheet (annual, 2023-12-31) — Current Deferred Revenue: 111000000.00
CNP balance_sheet (annual, 2023-12-31) — Current Liabilities: 3864000000.00
CNP cash_flow (annual, 2023-12-31) — Deferred Income Tax: 31000000.00
CNP cash_flow (annual, 2023-12-31) — Deferred Tax: 31000000.00
CNP cash_flow (annual, 2023-12-31) — Depreciation: 1092000000.00
CNP cash_flow (annual, 2023-12-31) — Depreciation Amortization Depletion: 1401000000.00
CNP income_statement (annual, 2023-12-31) — Depreciation Amortization Depletion Income Statement: 1401000000.00
CNP cash_flow (annual, 2023-12-31) — Depreciation And Amortization: 1401000000.00
CNP income_statement (annual, 2023-12-31) — Depreciation And Amortization In Income Statement: 1401000000.00
CNP balance_sheet (annual, 2023-12-31) — Derivative Product Liabilities: 3000000.00
CNP income_statement (annual, 2023-12-31) — Diluted Average Shares: 633000000.00
CNP income_statement (annual, 2023-12-31) — Diluted EPS: 1.37
CNP income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: 867000000.00
CNP cash_flow (annual, 2023-12-31) — Dividend Received Cfo: 0.00
CNP balance_sheet (annual, 2023-12-31) — Dividends Payable: 126000000.00
CNP income_statement (annual, 2023-12-31) — EBIT: 1788000000.00
CNP income_statement (annual, 2023-12-31) — EBITDA: 3189000000.00
CNP cash_flow (annual, 2023-12-31) — Earnings Losses From Equity Investments: 0.00
CNP balance_sheet (annual, 2023-12-31) — Employee Benefits: 572000000.00
CNP cash_flow (annual, 2023-12-31) — End Cash Position: 109000000.00
CNP balance_sheet (annual, 2023-12-31) — Financial Assets: 0.00
CNP cash_flow (annual, 2023-12-31) — Financing Cash Flow: 374000000.00
CNP cash_flow (annual, 2023-12-31) — Free Cash Flow: -524000000.00
CNP cash_flow (annual, 2023-12-31) — Gain Loss On Investment Securities: -4000000.00
CNP cash_flow (annual, 2023-12-31) — Gain Loss On Sale Of Business: 13000000.00
CNP income_statement (annual, 2023-12-31) — Gain On Sale Of Business: -13000000.00
CNP income_statement (annual, 2023-12-31) — Gain On Sale Of Security: 4000000.00
CNP balance_sheet (annual, 2023-12-31) — Gains Losses Not Affecting Retained Earnings: -35000000.00
CNP balance_sheet (annual, 2023-12-31) — Goodwill: 4160000000.00
CNP balance_sheet (annual, 2023-12-31) — Goodwill And Other Intangible Assets: 4160000000.00
CNP balance_sheet (annual, 2023-12-31) — Gross Accounts Receivable: 737000000.00
CNP balance_sheet (annual, 2023-12-31) — Gross PPE: 40396000000.00
CNP income_statement (annual, 2023-12-31) — Gross Profit: 3686000000.00
CNP balance_sheet (annual, 2023-12-31) — Hedging Assets Current: 0.00
CNP cash_flow (annual, 2023-12-31) — Income Tax Paid Supplemental Data: 215000000.00
CNP income_statement (annual, 2023-12-31) — Interest Expense: 701000000.00
CNP income_statement (annual, 2023-12-31) — Interest Expense Non Operating: 701000000.00
CNP cash_flow (annual, 2023-12-31) — Interest Paid Supplemental Data: 664000000.00
CNP balance_sheet (annual, 2023-12-31) — Interest Payable: 236000000.00
CNP balance_sheet (annual, 2023-12-31) — Inventory: 770000000.00
CNP balance_sheet (annual, 2023-12-31) — Invested Capital: 28285000000.00
CNP cash_flow (annual, 2023-12-31) — Investing Cash Flow: -4233000000.00
CNP cash_flow (annual, 2023-12-31) — Issuance Of Capital Stock: 0.00
CNP cash_flow (annual, 2023-12-31) — Issuance Of Debt: 6044000000.00
CNP balance_sheet (annual, 2023-12-31) — Long Term Debt: 17559000000.00
CNP balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 17559000000.00
CNP cash_flow (annual, 2023-12-31) — Long Term Debt Issuance: 6044000000.00
CNP cash_flow (annual, 2023-12-31) — Long Term Debt Payments: -3190000000.00
CNP cash_flow (annual, 2023-12-31) — Net Business Purchase And Sale: 144000000.00
CNP cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: 0.00
CNP balance_sheet (annual, 2023-12-31) — Net Debt: 18528000000.00
CNP income_statement (annual, 2023-12-31) — Net Income: 917000000.00
CNP income_statement (annual, 2023-12-31) — Net Income Common Stockholders: 867000000.00
CNP income_statement (annual, 2023-12-31) — Net Income Continuous Operations: 917000000.00
CNP income_statement (annual, 2023-12-31) — Net Income Discontinuous Operations: 0.00
CNP income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: 917000000.00
CNP income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: 917000000.00
CNP cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: 917000000.00
CNP income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: 917000000.00
CNP income_statement (annual, 2023-12-31) — Net Interest Income: -701000000.00
CNP cash_flow (annual, 2023-12-31) — Net Investment Purchase And Sale: 0.00
CNP cash_flow (annual, 2023-12-31) — Net Issuance Payments Of Debt: 1789000000.00
CNP cash_flow (annual, 2023-12-31) — Net Long Term Debt Issuance: 2854000000.00
CNP income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: -701000000.00
CNP cash_flow (annual, 2023-12-31) — Net Other Financing Charges: -80000000.00
CNP cash_flow (annual, 2023-12-31) — Net Other Investing Changes: 24000000.00
CNP balance_sheet (annual, 2023-12-31) — Net PPE: 29853000000.00
CNP cash_flow (annual, 2023-12-31) — Net Preferred Stock Issuance: -800000000.00
CNP cash_flow (annual, 2023-12-31) — Net Short Term Debt Issuance: -1065000000.00
CNP balance_sheet (annual, 2023-12-31) — Net Tangible Assets: 5507000000.00
CNP balance_sheet (annual, 2023-12-31) — Non Current Deferred Liabilities: 4079000000.00
CNP balance_sheet (annual, 2023-12-31) — Non Current Deferred Taxes Liabilities: 4079000000.00
CNP balance_sheet (annual, 2023-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 572000000.00
CNP income_statement (annual, 2023-12-31) — Normalized EBITDA: 3198000000.00
CNP income_statement (annual, 2023-12-31) — Normalized Income: 924560000.00
CNP cash_flow (annual, 2023-12-31) — Operating Cash Flow: 3877000000.00
CNP cash_flow (annual, 2023-12-31) — Operating Gains Losses: 9000000.00
CNP income_statement (annual, 2023-12-31) — Operating Income: 1760000000.00
CNP income_statement (annual, 2023-12-31) — Operating Revenue: 8696000000.00
CNP balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 631225829.00
CNP balance_sheet (annual, 2023-12-31) — Other Current Assets: 306000000.00
CNP balance_sheet (annual, 2023-12-31) — Other Current Borrowings: 1059000000.00
CNP balance_sheet (annual, 2023-12-31) — Other Current Liabilities: 1124000000.00
CNP balance_sheet (annual, 2023-12-31) — Other Equity Adjustments: -35000000.00
CNP income_statement (annual, 2023-12-31) — Other Income Expense: 28000000.00
CNP balance_sheet (annual, 2023-12-31) — Other Inventories: 197000000.00
CNP cash_flow (annual, 2023-12-31) — Other Non Cash Items: 28000000.00
CNP balance_sheet (annual, 2023-12-31) — Other Non Current Assets: 162000000.00
CNP balance_sheet (annual, 2023-12-31) — Other Non Current Liabilities: 766000000.00
CNP income_statement (annual, 2023-12-31) — Other Non Operating Income Expenses: 37000000.00
CNP balance_sheet (annual, 2023-12-31) — Other Properties: 3372000000.00
CNP balance_sheet (annual, 2023-12-31) — Other Short Term Investments: 541000000.00
CNP income_statement (annual, 2023-12-31) — Other Taxes: 525000000.00
CNP balance_sheet (annual, 2023-12-31) — Payables: 1334000000.00
CNP balance_sheet (annual, 2023-12-31) — Payables And Accrued Expenses: 1570000000.00
CNP balance_sheet (annual, 2023-12-31) — Preferred Stock: 0.00
CNP cash_flow (annual, 2023-12-31) — Preferred Stock Dividend Paid: -50000000.00
CNP income_statement (annual, 2023-12-31) — Preferred Stock Dividends: 50000000.00
CNP cash_flow (annual, 2023-12-31) — Preferred Stock Payments: -800000000.00
CNP income_statement (annual, 2023-12-31) — Pretax Income: 1087000000.00
CNP cash_flow (annual, 2023-12-31) — Purchase Of Business: 0.00
CNP balance_sheet (annual, 2023-12-31) — Receivables: 1320000000.00
CNP income_statement (annual, 2023-12-31) — Reconciled Cost Of Revenue: 5010000000.00
CNP income_statement (annual, 2023-12-31) — Reconciled Depreciation: 1401000000.00
CNP cash_flow (annual, 2023-12-31) — Repayment Of Debt: -4255000000.00
CNP cash_flow (annual, 2023-12-31) — Repurchase Of Capital Stock: -800000000.00
CNP balance_sheet (annual, 2023-12-31) — Retained Earnings: 1092000000.00
CNP cash_flow (annual, 2023-12-31) — Sale Of Business: 144000000.00
CNP cash_flow (annual, 2023-12-31) — Sale Of Investment: 0.00
CNP balance_sheet (annual, 2023-12-31) — Share Issued: 631225995.00
CNP cash_flow (annual, 2023-12-31) — Short Term Debt Payments: -1065000000.00
CNP income_statement (annual, 2023-12-31) — Special Income Charges: -13000000.00
CNP balance_sheet (annual, 2023-12-31) — Stockholders Equity: 9667000000.00
CNP balance_sheet (annual, 2023-12-31) — Tangible Book Value: 5507000000.00
CNP income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: -1440000.00
CNP income_statement (annual, 2023-12-31) — Tax Provision: 170000000.00
CNP income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.16
CNP balance_sheet (annual, 2023-12-31) — Taxes Receivable: 94000000.00
CNP balance_sheet (annual, 2023-12-31) — Total Assets: 39715000000.00
CNP balance_sheet (annual, 2023-12-31) — Total Capitalization: 27226000000.00
CNP balance_sheet (annual, 2023-12-31) — Total Debt: 18618000000.00
CNP balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: 9667000000.00
CNP income_statement (annual, 2023-12-31) — Total Expenses: 6936000000.00
CNP balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 30048000000.00
CNP balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 36688000000.00
CNP balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 26184000000.00
CNP income_statement (annual, 2023-12-31) — Total Operating Income As Reported: 1760000000.00
CNP balance_sheet (annual, 2023-12-31) — Total Tax Payable: 291000000.00
CNP income_statement (annual, 2023-12-31) — Total Unusual Items: -9000000.00
CNP income_statement (annual, 2023-12-31) — Total Unusual Items Excluding Goodwill: -9000000.00
CNP balance_sheet (annual, 2023-12-31) — Treasury Shares Number: 166.00
CNP balance_sheet (annual, 2023-12-31) — Working Capital: -837000000.00
CNP income_statement (quarterly, 2024-09-30) — Basic Average Shares: 648000000.00
CNP income_statement (quarterly, 2024-09-30) — Basic EPS: 0.30
CNP cash_flow (quarterly, 2024-09-30) — Change In Other Working Capital: -200000000.00
CNP balance_sheet (quarterly, 2024-09-30) — Derivative Product Liabilities: 2000000.00
CNP income_statement (quarterly, 2024-09-30) — Diluted Average Shares: 648000000.00
CNP income_statement (quarterly, 2024-09-30) — Diluted EPS: 0.30
CNP cash_flow (quarterly, 2024-09-30) — Gain Loss On Investment Securities: -1000000.00
CNP cash_flow (quarterly, 2024-09-30) — Gain Loss On Sale Of Business: 0.00
CNP balance_sheet (quarterly, 2024-09-30) — Hedging Assets Current: 1000000.00
CNP cash_flow (quarterly, 2024-09-30) — Preferred Stock Dividend Paid: 0.00
CNP income_statement (annual, 2024-12-31) — +Operating Expense: 1986000000.00
CNP income_statement (annual, 2024-12-31) — +Total Revenue: 8643000000.00
CNP balance_sheet (annual, 2024-12-31) — Accounts Payable: 1320000000.00
CNP balance_sheet (annual, 2024-12-31) — Accounts Receivable: 717000000.00
CNP balance_sheet (annual, 2024-12-31) — Accumulated Depreciation: -10578000000.00
CNP balance_sheet (annual, 2024-12-31) — Additional Paid In Capital: 9105000000.00
CNP balance_sheet (annual, 2024-12-31) — Allowance For Doubtful Accounts Receivable: -28000000.00
CNP cash_flow (annual, 2024-12-31) — Amortization Cash Flow: 262000000.00
CNP cash_flow (annual, 2024-12-31) — Amortization Of Intangibles: 262000000.00
CNP balance_sheet (annual, 2024-12-31) — Assets Held For Sale Current: 1361000000.00
CNP income_statement (annual, 2024-12-31) — Basic Average Shares: 643000000.00
CNP income_statement (annual, 2024-12-31) — Basic EPS: 1.58
CNP cash_flow (annual, 2024-12-31) — Beginning Cash Position: 109000000.00
CNP cash_flow (annual, 2024-12-31) — Capital Expenditure: -4513000000.00
CNP cash_flow (annual, 2024-12-31) — Capital Expenditure Reported: -4513000000.00
CNP balance_sheet (annual, 2024-12-31) — Capital Stock: 6000000.00
CNP balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 24000000.00
CNP balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 585000000.00
CNP cash_flow (annual, 2024-12-31) — Cash Dividends Paid: -522000000.00
CNP cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Financing Activities: 2271000000.00
CNP cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Investing Activities: -4489000000.00
CNP cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Operating Activities: 2139000000.00
CNP cash_flow (annual, 2024-12-31) — Change In Account Payable: 210000000.00
CNP cash_flow (annual, 2024-12-31) — Change In Inventory: 42000000.00
CNP cash_flow (annual, 2024-12-31) — Change In Other Current Assets: -760000000.00
CNP cash_flow (annual, 2024-12-31) — Change In Other Current Liabilities: 74000000.00
CNP cash_flow (annual, 2024-12-31) — Change In Other Working Capital: -659000000.00
CNP cash_flow (quarterly, 2024-12-31) — Change In Other Working Capital: -21000000.00
CNP cash_flow (annual, 2024-12-31) — Change In Payable: 210000000.00
CNP cash_flow (annual, 2024-12-31) — Change In Payables And Accrued Expense: 210000000.00
CNP cash_flow (annual, 2024-12-31) — Change In Receivables: -84000000.00
CNP cash_flow (annual, 2024-12-31) — Change In Working Capital: -518000000.00
CNP cash_flow (annual, 2024-12-31) — Changes In Account Receivables: -84000000.00
CNP cash_flow (quarterly, 2024-12-31) — Changes In Account Receivables: -229000000.00
CNP cash_flow (annual, 2024-12-31) — Changes In Cash: -79000000.00
CNP balance_sheet (annual, 2024-12-31) — Common Stock: 6000000.00
CNP cash_flow (annual, 2024-12-31) — Common Stock Dividend Paid: -522000000.00
CNP balance_sheet (annual, 2024-12-31) — Common Stock Equity: 10666000000.00
CNP cash_flow (annual, 2024-12-31) — Common Stock Issuance: 494000000.00
CNP cash_flow (quarterly, 2024-12-31) — Common Stock Issuance: 0.00
CNP income_statement (annual, 2024-12-31) — Cost Of Revenue: 4667000000.00
CNP balance_sheet (annual, 2024-12-31) — Current Accrued Expenses: 274000000.00
CNP balance_sheet (annual, 2024-12-31) — Current Assets: 4381000000.00
CNP balance_sheet (annual, 2024-12-31) — Current Debt: 566000000.00
CNP balance_sheet (annual, 2024-12-31) — Current Debt And Capital Lease Obligation: 566000000.00
CNP balance_sheet (annual, 2024-12-31) — Current Deferred Liabilities: 93000000.00
CNP balance_sheet (annual, 2024-12-31) — Current Deferred Revenue: 93000000.00
CNP balance_sheet (annual, 2024-12-31) — Current Liabilities: 4045000000.00
CNP cash_flow (annual, 2024-12-31) — Deferred Income Tax: 221000000.00
CNP cash_flow (annual, 2024-12-31) — Deferred Tax: 221000000.00
CNP cash_flow (annual, 2024-12-31) — Depreciation: 1177000000.00
CNP cash_flow (annual, 2024-12-31) — Depreciation Amortization Depletion: 1439000000.00
CNP income_statement (annual, 2024-12-31) — Depreciation Amortization Depletion Income Statement: 1439000000.00
CNP cash_flow (annual, 2024-12-31) — Depreciation And Amortization: 1439000000.00
CNP income_statement (annual, 2024-12-31) — Depreciation And Amortization In Income Statement: 1439000000.00
CNP income_statement (annual, 2024-12-31) — Diluted Average Shares: 644000000.00
CNP income_statement (annual, 2024-12-31) — Diluted EPS: 1.58
CNP income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: 1019000000.00
CNP balance_sheet (annual, 2024-12-31) — Dividends Payable: 143000000.00
CNP income_statement (annual, 2024-12-31) — EBIT: 2052000000.00
CNP income_statement (annual, 2024-12-31) — EBITDA: 3491000000.00
CNP balance_sheet (annual, 2024-12-31) — Employee Benefits: 550000000.00
CNP cash_flow (annual, 2024-12-31) — End Cash Position: 30000000.00
CNP cash_flow (annual, 2024-12-31) — Financing Cash Flow: 2271000000.00
CNP cash_flow (annual, 2024-12-31) — Free Cash Flow: -2374000000.00
CNP cash_flow (annual, 2024-12-31) — Gain Loss On Investment Securities: -6000000.00
CNP cash_flow (quarterly, 2024-12-31) — Gain Loss On Investment Securities: -2000000.00
CNP cash_flow (annual, 2024-12-31) — Gain Loss On Sale Of Business: 0.00
CNP cash_flow (quarterly, 2024-12-31) — Gain Loss On Sale Of Business: 0.00
CNP income_statement (annual, 2024-12-31) — Gain On Sale Of Business: 0.00
CNP income_statement (annual, 2024-12-31) — Gain On Sale Of Security: 6000000.00
CNP income_statement (quarterly, 2024-12-31) — Gain On Sale Of Security: 2000000.00
CNP balance_sheet (annual, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: -17000000.00
CNP balance_sheet (annual, 2024-12-31) — Goodwill: 3943000000.00
CNP balance_sheet (annual, 2024-12-31) — Goodwill And Other Intangible Assets: 3943000000.00
CNP balance_sheet (annual, 2024-12-31) — Gross Accounts Receivable: 745000000.00
CNP balance_sheet (annual, 2024-12-31) — Gross PPE: 42667000000.00
CNP income_statement (annual, 2024-12-31) — Gross Profit: 3976000000.00
CNP income_statement (annual, 2024-12-31) — Interest Expense: 838000000.00
CNP income_statement (annual, 2024-12-31) — Interest Expense Non Operating: 838000000.00
CNP cash_flow (annual, 2024-12-31) — Interest Paid Supplemental Data: 805000000.00
CNP balance_sheet (annual, 2024-12-31) — Interest Payable: 274000000.00
CNP balance_sheet (annual, 2024-12-31) — Inventory: 714000000.00
CNP balance_sheet (annual, 2024-12-31) — Invested Capital: 31629000000.00
CNP cash_flow (annual, 2024-12-31) — Investing Cash Flow: -4489000000.00
CNP cash_flow (annual, 2024-12-31) — Issuance Of Capital Stock: 494000000.00
CNP cash_flow (quarterly, 2024-12-31) — Issuance Of Capital Stock: 0.00
CNP cash_flow (annual, 2024-12-31) — Issuance Of Debt: 3955000000.00
CNP balance_sheet (annual, 2024-12-31) — Long Term Debt: 20397000000.00
CNP balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 20397000000.00
CNP cash_flow (annual, 2024-12-31) — Long Term Debt Issuance: 3955000000.00
CNP cash_flow (annual, 2024-12-31) — Long Term Debt Payments: -1050000000.00
CNP cash_flow (annual, 2024-12-31) — Net Business Purchase And Sale: 0.00
CNP cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: 494000000.00
CNP cash_flow (quarterly, 2024-12-31) — Net Common Stock Issuance: 0.00
CNP balance_sheet (annual, 2024-12-31) — Net Debt: 20939000000.00
CNP income_statement (annual, 2024-12-31) — Net Income: 1019000000.00
CNP income_statement (annual, 2024-12-31) — Net Income Common Stockholders: 1019000000.00
CNP income_statement (annual, 2024-12-31) — Net Income Continuous Operations: 1019000000.00
CNP income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: 1019000000.00
CNP income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: 1019000000.00
CNP cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: 1019000000.00
CNP income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: 1019000000.00
CNP income_statement (annual, 2024-12-31) — Net Interest Income: -838000000.00
CNP cash_flow (annual, 2024-12-31) — Net Investment Purchase And Sale: 0.00
CNP cash_flow (annual, 2024-12-31) — Net Issuance Payments Of Debt: 2362000000.00
CNP cash_flow (annual, 2024-12-31) — Net Long Term Debt Issuance: 2905000000.00
CNP income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: -838000000.00
CNP cash_flow (annual, 2024-12-31) — Net Other Financing Charges: -63000000.00
CNP cash_flow (annual, 2024-12-31) — Net Other Investing Changes: 24000000.00
CNP balance_sheet (annual, 2024-12-31) — Net PPE: 32089000000.00
CNP cash_flow (annual, 2024-12-31) — Net Preferred Stock Issuance: 0.00
CNP cash_flow (quarterly, 2024-12-31) — Net Preferred Stock Issuance: 0.00
CNP cash_flow (annual, 2024-12-31) — Net Short Term Debt Issuance: -543000000.00
CNP balance_sheet (annual, 2024-12-31) — Net Tangible Assets: 6723000000.00
CNP balance_sheet (annual, 2024-12-31) — Non Current Deferred Liabilities: 4389000000.00
CNP balance_sheet (annual, 2024-12-31) — Non Current Deferred Taxes Liabilities: 4389000000.00
CNP balance_sheet (annual, 2024-12-31) — Non Current Pension And Other Postretirement Benefit Plans: 550000000.00
CNP income_statement (annual, 2024-12-31) — Normalized EBITDA: 3485000000.00
CNP income_statement (annual, 2024-12-31) — Normalized Income: 1013960000.00
CNP cash_flow (annual, 2024-12-31) — Operating Cash Flow: 2139000000.00
CNP cash_flow (annual, 2024-12-31) — Operating Gains Losses: -6000000.00
CNP income_statement (annual, 2024-12-31) — Operating Income: 1990000000.00
CNP income_statement (annual, 2024-12-31) — Operating Revenue: 8643000000.00
CNP balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 651727276.00
CNP balance_sheet (annual, 2024-12-31) — Other Current Assets: 362000000.00
CNP balance_sheet (annual, 2024-12-31) — Other Current Borrowings: 566000000.00
CNP balance_sheet (annual, 2024-12-31) — Other Current Liabilities: 1320000000.00
CNP balance_sheet (annual, 2024-12-31) — Other Equity Adjustments: -17000000.00
CNP income_statement (annual, 2024-12-31) — Other Income Expense: 62000000.00
CNP balance_sheet (annual, 2024-12-31) — Other Inventories: 173000000.00
CNP cash_flow (annual, 2024-12-31) — Other Non Cash Items: -16000000.00
CNP balance_sheet (annual, 2024-12-31) — Other Non Current Assets: 247000000.00
CNP balance_sheet (annual, 2024-12-31) — Other Non Current Liabilities: 722000000.00
CNP income_statement (annual, 2024-12-31) — Other Non Operating Income Expenses: 56000000.00
CNP balance_sheet (annual, 2024-12-31) — Other Properties: 3774000000.00
CNP balance_sheet (quarterly, 2024-12-31) — Other Properties: 3774000000.00
CNP balance_sheet (annual, 2024-12-31) — Other Short Term Investments: 561000000.00
CNP income_statement (annual, 2024-12-31) — Other Taxes: 547000000.00
CNP balance_sheet (annual, 2024-12-31) — Payables: 1792000000.00
CNP balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 2066000000.00
CNP balance_sheet (annual, 2024-12-31) — Preferred Stock: 0.00
CNP balance_sheet (quarterly, 2024-12-31) — Preferred Stock: 0.00
CNP cash_flow (annual, 2024-12-31) — Preferred Stock Dividend Paid: 0.00
CNP cash_flow (quarterly, 2024-12-31) — Preferred Stock Dividend Paid: 0.00
CNP cash_flow (annual, 2024-12-31) — Preferred Stock Payments: 0.00
CNP cash_flow (quarterly, 2024-12-31) — Preferred Stock Payments: 0.00
CNP income_statement (annual, 2024-12-31) — Pretax Income: 1214000000.00
CNP cash_flow (annual, 2024-12-31) — Purchase Of Business: 0.00
CNP balance_sheet (annual, 2024-12-31) — Receivables: 1359000000.00
CNP income_statement (annual, 2024-12-31) — Reconciled Cost Of Revenue: 4667000000.00
CNP income_statement (annual, 2024-12-31) — Reconciled Depreciation: 1439000000.00
CNP cash_flow (annual, 2024-12-31) — Repayment Of Debt: -1593000000.00
CNP cash_flow (annual, 2024-12-31) — Repurchase Of Capital Stock: 0.00
CNP cash_flow (quarterly, 2024-12-31) — Repurchase Of Capital Stock: 0.00
CNP balance_sheet (annual, 2024-12-31) — Retained Earnings: 1572000000.00
CNP cash_flow (annual, 2024-12-31) — Sale Of Business: 0.00
CNP cash_flow (annual, 2024-12-31) — Sale Of Investment: 0.00
CNP balance_sheet (annual, 2024-12-31) — Share Issued: 651727442.00
CNP cash_flow (annual, 2024-12-31) — Short Term Debt Payments: -543000000.00
CNP income_statement (annual, 2024-12-31) — Special Income Charges: 0.00
CNP balance_sheet (annual, 2024-12-31) — Stockholders Equity: 10666000000.00
CNP balance_sheet (annual, 2024-12-31) — Tangible Book Value: 6723000000.00
CNP income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: 960000.00
CNP income_statement (annual, 2024-12-31) — Tax Provision: 195000000.00
CNP income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.16
CNP balance_sheet (annual, 2024-12-31) — Taxes Receivable: 121000000.00
CNP balance_sheet (annual, 2024-12-31) — Total Assets: 43768000000.00
CNP balance_sheet (annual, 2024-12-31) — Total Capitalization: 31063000000.00
CNP balance_sheet (annual, 2024-12-31) — Total Debt: 20963000000.00
CNP balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 10666000000.00
CNP income_statement (annual, 2024-12-31) — Total Expenses: 6653000000.00
CNP balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 33102000000.00
CNP balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 39387000000.00
CNP balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 29057000000.00
CNP income_statement (annual, 2024-12-31) — Total Operating Income As Reported: 1990000000.00
CNP balance_sheet (annual, 2024-12-31) — Total Tax Payable: 329000000.00
CNP income_statement (annual, 2024-12-31) — Total Unusual Items: 6000000.00
CNP income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: 6000000.00
CNP balance_sheet (annual, 2024-12-31) — Treasury Shares Number: 166.00
CNP balance_sheet (annual, 2024-12-31) — Working Capital: 336000000.00
CNP income_statement (quarterly, 2025-03-31) — +Operating Expense: 517000000.00
CNP income_statement (quarterly, 2025-03-31) — +Total Revenue: 2920000000.00
CNP balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 1042000000.00
CNP balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 869000000.00
CNP balance_sheet (quarterly, 2025-03-31) — Accumulated Depreciation: -10768000000.00
CNP balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 9097000000.00
CNP balance_sheet (quarterly, 2025-03-31) — Allowance For Doubtful Accounts Receivable: -30000000.00
CNP balance_sheet (quarterly, 2025-03-31) — Assets Held For Sale Current: 0.00
CNP income_statement (quarterly, 2025-03-31) — Basic Average Shares: 652161000.00
CNP income_statement (quarterly, 2025-03-31) — Basic EPS: 0.45
CNP cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 30000000.00
CNP cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -1038000000.00
CNP cash_flow (quarterly, 2025-03-31) — Capital Expenditure Reported: -1038000000.00
CNP balance_sheet (quarterly, 2025-03-31) — Capital Stock: 6000000.00
CNP balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 1254000000.00
CNP balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 1894000000.00
CNP cash_flow (quarterly, 2025-03-31) — Cash Dividends Paid: -143000000.00
CNP cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: 1053000000.00
CNP cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: -234000000.00
CNP cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: 410000000.00
CNP cash_flow (quarterly, 2025-03-31) — Change In Account Payable: -216000000.00
CNP cash_flow (quarterly, 2025-03-31) — Change In Inventory: 110000000.00
CNP cash_flow (quarterly, 2025-03-31) — Change In Other Current Assets: 204000000.00
CNP cash_flow (quarterly, 2025-03-31) — Change In Other Current Liabilities: -249000000.00
CNP cash_flow (quarterly, 2025-03-31) — Change In Other Working Capital: -85000000.00
CNP cash_flow (quarterly, 2025-03-31) — Change In Payable: -216000000.00
CNP cash_flow (quarterly, 2025-03-31) — Change In Payables And Accrued Expense: -216000000.00
CNP cash_flow (quarterly, 2025-03-31) — Change In Receivables: -125000000.00
CNP cash_flow (quarterly, 2025-03-31) — Change In Working Capital: -276000000.00
CNP cash_flow (quarterly, 2025-03-31) — Changes In Account Receivables: -125000000.00
CNP cash_flow (quarterly, 2025-03-31) — Changes In Cash: 1229000000.00
CNP balance_sheet (quarterly, 2025-03-31) — Common Stock: 6000000.00
CNP cash_flow (quarterly, 2025-03-31) — Common Stock Dividend Paid: -143000000.00
CNP balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 10955000000.00
CNP cash_flow (quarterly, 2025-03-31) — Common Stock Issuance: 0.00
CNP income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 1754000000.00
CNP balance_sheet (quarterly, 2025-03-31) — Current Accrued Expenses: 235000000.00
CNP balance_sheet (quarterly, 2025-03-31) — Current Assets: 4136000000.00
CNP balance_sheet (quarterly, 2025-03-31) — Current Debt: 1825000000.00
CNP balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 1825000000.00
CNP balance_sheet (quarterly, 2025-03-31) — Current Deferred Liabilities: 94000000.00
CNP balance_sheet (quarterly, 2025-03-31) — Current Deferred Revenue: 94000000.00
CNP balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 4441000000.00
CNP cash_flow (quarterly, 2025-03-31) — Deferred Income Tax: 45000000.00
CNP cash_flow (quarterly, 2025-03-31) — Deferred Tax: 45000000.00
CNP cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 363000000.00
CNP income_statement (quarterly, 2025-03-31) — Depreciation Amortization Depletion Income Statement: 363000000.00
CNP cash_flow (quarterly, 2025-03-31) — Depreciation And Amortization: 363000000.00
CNP income_statement (quarterly, 2025-03-31) — Depreciation And Amortization In Income Statement: 363000000.00
CNP income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 653319000.00
CNP income_statement (quarterly, 2025-03-31) — Diluted EPS: 0.45
CNP income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: 297000000.00
CNP balance_sheet (quarterly, 2025-03-31) — Dividends Payable: 0.00
CNP income_statement (quarterly, 2025-03-31) — EBIT: 616000000.00
CNP income_statement (quarterly, 2025-03-31) — EBITDA: 979000000.00
CNP balance_sheet (quarterly, 2025-03-31) — Employee Benefits: 491000000.00
CNP cash_flow (quarterly, 2025-03-31) — End Cash Position: 1259000000.00
CNP cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: 1053000000.00
CNP cash_flow (quarterly, 2025-03-31) — Free Cash Flow: -628000000.00
CNP income_statement (quarterly, 2025-03-31) — Gain On Sale Of Business: -43000000.00
CNP balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: -17000000.00
CNP balance_sheet (quarterly, 2025-03-31) — Goodwill: 3943000000.00
CNP balance_sheet (quarterly, 2025-03-31) — Goodwill And Other Intangible Assets: 3943000000.00
CNP balance_sheet (quarterly, 2025-03-31) — Gross Accounts Receivable: 899000000.00
CNP balance_sheet (quarterly, 2025-03-31) — Gross PPE: 43868000000.00
CNP income_statement (quarterly, 2025-03-31) — Gross Profit: 1166000000.00
CNP income_statement (quarterly, 2025-03-31) — Interest Expense: 238000000.00
CNP income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 238000000.00
CNP cash_flow (quarterly, 2025-03-31) — Interest Paid Supplemental Data: 290000000.00
CNP balance_sheet (quarterly, 2025-03-31) — Interest Payable: 235000000.00
CNP balance_sheet (quarterly, 2025-03-31) — Inventory: 608000000.00
CNP balance_sheet (quarterly, 2025-03-31) — Invested Capital: 33142000000.00
CNP cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: -234000000.00
CNP cash_flow (quarterly, 2025-03-31) — Issuance Of Capital Stock: 0.00
CNP cash_flow (quarterly, 2025-03-31) — Issuance Of Debt: 1234000000.00
CNP balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 20362000000.00
CNP balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 20362000000.00
CNP cash_flow (quarterly, 2025-03-31) — Long Term Debt Issuance: 665000000.00
CNP cash_flow (quarterly, 2025-03-31) — Long Term Debt Payments: -11000000.00
CNP cash_flow (quarterly, 2025-03-31) — Net Business Purchase And Sale: 1219000000.00
CNP cash_flow (quarterly, 2025-03-31) — Net Common Stock Issuance: 0.00
CNP balance_sheet (quarterly, 2025-03-31) — Net Debt: 20933000000.00
CNP income_statement (quarterly, 2025-03-31) — Net Income: 297000000.00
CNP income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: 297000000.00
CNP income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 297000000.00
CNP income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: 297000000.00
CNP income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: 297000000.00
CNP cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: 297000000.00
CNP income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 297000000.00
CNP income_statement (quarterly, 2025-03-31) — Net Interest Income: -238000000.00
CNP cash_flow (quarterly, 2025-03-31) — Net Issuance Payments Of Debt: 1220000000.00
CNP cash_flow (quarterly, 2025-03-31) — Net Long Term Debt Issuance: 654000000.00
CNP income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: -238000000.00
CNP cash_flow (quarterly, 2025-03-31) — Net Other Financing Charges: -24000000.00
CNP cash_flow (quarterly, 2025-03-31) — Net Other Investing Changes: -415000000.00
CNP balance_sheet (quarterly, 2025-03-31) — Net PPE: 33100000000.00
CNP cash_flow (quarterly, 2025-03-31) — Net Short Term Debt Issuance: 566000000.00
CNP balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 7012000000.00
CNP balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Liabilities: 4477000000.00
CNP balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Liabilities: 4477000000.00
CNP balance_sheet (quarterly, 2025-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 491000000.00
CNP income_statement (quarterly, 2025-03-31) — Normalized EBITDA: 1022000000.00
CNP income_statement (quarterly, 2025-03-31) — Normalized Income: 330970000.00
CNP cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: 410000000.00
CNP cash_flow (quarterly, 2025-03-31) — Operating Gains Losses: 43000000.00
CNP income_statement (quarterly, 2025-03-31) — Operating Income: 649000000.00
CNP income_statement (quarterly, 2025-03-31) — Operating Revenue: 2920000000.00
CNP balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 652726754.00
CNP balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 281000000.00
CNP balance_sheet (quarterly, 2025-03-31) — Other Current Borrowings: 1825000000.00
CNP balance_sheet (quarterly, 2025-03-31) — Other Current Liabilities: 1043000000.00
CNP balance_sheet (quarterly, 2025-03-31) — Other Equity Adjustments: -17000000.00
CNP income_statement (quarterly, 2025-03-31) — Other Income Expense: -33000000.00
CNP balance_sheet (quarterly, 2025-03-31) — Other Inventories: 88000000.00
CNP cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: -62000000.00
CNP balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 221000000.00